Mercia’s Life Sciences helping the COVID-19 fight

Life sciences is one of Mercia’s areas of focus and investment expertise. Mercia’s investment track record in the life sciences sector stretches back over 15 years. Today, Mercia manages a portfolio of over 400 businesses through its venture capital, private equity and debt managed funds, of which c 10% by number are in the life

Mercia life sciences portfolio: Hearing from the companies

Following Mercia‘s recent life sciences portfolio, three of Mercia’s portfolio CEOs talk about their businesses with Edison: John Burt, CEO of Medherant; John von Benecke, CEO of Locate Bio; and Dr Harry Lamble, CEO of Sense Biodetection. They discuss the support they have received as part of the Mercia family, how their businesses have progressed,

WEBINAR: What is Performance Marketing and how it will impact your bottom line

Eldad Sotnick-Yogev is a natural advisor who focuses on adding value through better execution. He’s sharing the foundations of ‘Performance Marketing’. With 20 years’ experience leading performance marketing teams as well as paid, owned and earned strategies for global and local clients, you’ll learn from a motivating and methodical practitioner, and team leader. His experience includes Mindshare Worldwide,

WEBINAR: Atlas Cloud – Hybrid Working

Earlier this year Pete Watson and Ben Tomlinson of Atlas Cloud, undertook one of the largest surveys of the working habits of British office workers since the announcement of the nationwide coronavirus lockdown. The research looked into the working habits of more than 3,000 office workers during the coronavirus pandemic, providing valuable insight into the working lives

WEBINAR: EIS carry back to the 2019/20 tax year

The Mercia EIS Fund will have its next close on 30th September. This will be the last opportunity to invest the entire EIS Fund before the 5th April 2021, which enables carry back to the 2019/2020 tax year. Dr. Paul Mattick, Russell Fryer and Chris Kilroy hosted the latest webinar titled, ‘EIS carry back to